COVID-19

Steven C. Anderson, FASAE, CAE, IOM, president and CEO of the National Association of Chain Drug Stores, has been invited to join the office of Health and Human Services’ new COVID-19 Vaccine Consultation Panel.

As increasing numbers of COVID-19 patients require intubation, aerosol containment devices have been in high demand, including improvised protection strategies and devices.

Phase 1/2 trials show promising results as the study moves into phase 2/3.

Along with the duty to care for patients with COVID-19 is the psychological burden that develops in frontline care professionals, such as pharmacists.

Contrary to earlier data, a new study from the University of California at San Francisco (UCSF) suggests that younger age may not reduce the severity of coronavirus disease 2019 (COVID-19).

Results of the COVID-19 and Cancer Consortium cohort study were presented during the 2020 American Society of Clinical Virtual Scientific Program.

Cancer medications contribute substantially to the cost of health care in the United States, with 8 of the 10 most expensive drugs indicated for the treatment of cancer

The goal of the current format for retail pharmacy services is to continue providing people with the medications they need to maintain their health and longevity during the coronavirus disease 2019 pandemic.

As a chronic respiratory disease, asthma has been considered a risk factor for COVID-19 by many experts and clinicians.

Top news of the week from Pharmacy Times®.

Walgreens and DoorDash plan to offer more than 5000 items for delivery on the DoorDash platform and will expand the service to other major markets, starting with Cincinnati, Cleveland, Minneapolis, Oklahoma City, Phoenix, Sacramento, and Seattle by the end of summer 2020.

The findings indicate that front-line health care workers are at high risk for COVID-19 and that many health care workers with the virus may not have typical symptoms of a respiratory infection, according to the study authors.

Each patient represents a unique set of challenges that requires focus and knowledge.

The current pandemic has been trauma-inducing for many and telehealth needs to rise to the occasion.

Researchers conducted an online study with 371 participants who viewed a COVID-19 screening session between a hotline agent, chatbot or human, and a user with mild or severe symptoms, according to a press release.

If successful in clinical trials and pending regulatory approval, Pfizer Inc and BioNTech expect to manufacture up to 100 million doses of a COVID-19 vaccine by the end of 2020.

It is likely that in the coronavirus disease 2019 era and its aftermath, we may see worsening adherence to therapy due to known factors that affect adherence and others that are unique to what is happening currently.

Emerging evidence is showing that COVID-19 symptoms may still persist even after recovery.

Pharmacists need new tools to reduce administrative burden and provide the best care to patients.

Contrary to World Health Organization recommendations, the benefits of steroids used in inhalers and nebulizers outweigh the risks.

Two mRNA- based vaccine candidates are currently in development by Pfizer and BioNTech.

The COVID-19 pandemic made a convincing argument to employers of having a robust and sound communication strategy to their employees.

Elderly, critically ill COVID-19 patients on lopinavir and ritonavir show an increased risk of bradycardia

According to the researchers, N95 masks and surgical masks, along with vacuum cleaner filters that can be inserted into filter pockets in cloth masks are the next best options. The vacuum filters reduced infection risk by 83% for a 30-second exposure and 58% for 20-minute exposure.

The Pharmacy Times® Pharmacy Focus podcast provides the latest industry news and information, thought-leader insights, clinical updates, patient counseling tools, and innovative solutions for the everyday practice and business of pharmacy.

According to a recent analysis published in the Annals of the American Thoracic Society, Black individuals are twice as likely as White individuals to test positive for COVID-19.

Top news of the week from Pharmacy Times®.

Ensuring equitable distribution of remdesivir in virus hot spots can help increase the capacity of intensive care unites.

According to an online survey of more than 53,000 Americans using PPIs, once or twice daily use significantly increases the likelihood of a positive test for COVID-19.

The von Willebrand factor may be the reason why coronavirus disease 2019 presents itself so differently in each person.